Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Comparative Effectiveness Research: Do Employers Care? What Will They Do? What About Productivity?

This article discusses a survey of employers, conducted by the Benfield Group and supported by the National Pharmaceutical Council, that found that one of the benefits employers are looking for from comparative effectiveness research (CER) is more information about which treatments help with productivity. While data is beginning to emerge regarding the links between good health, productivity and employee wellness programs, this survey shows that most companies (or the benefit consultants they work with) do not have access to the information or any ability to use it in their decision-making.

Specifically, while fewer than one-third of employers or their vendors currently use information about absence, disability and return to work assessing the impact of alternative treatments, 70 percent indicate that such information would be “Important” or “Very Important” within CER. And, while fewer than 25% now use information about the impact of alternative treatments on work productivity in making decisions, over 60% rate this information as “Important” or “Very Important” in CER.

In a more direct analysis of the benefit of CER to employers, respondents were asked how they would handle two specific scenarios related to treatments for low back pain and diabetes. According to the findings, employers are generally more likely to take action based on CER evidence regarding diabetes. The reasons given include the “perceived higher total costs” of treating diabetes and a belief that it would be easier to make changes to address diabetes based on “already generally accepted guidelines for treatment.”

In addition to productivity related information, additional survey findings of note include clear messages about what other types of information employers want: “clinical outcomes of alternative treatments; information comparing utilization and cost of treatments; information about which treatments work best for specific population, and; comparative safety of alternative treatments.”

Although a subscription to the JOEM is required to read this article, the full study, survey instrument and video are available on NPC's website.

Blog Post

Why You Need to Register for Our Health Care Quality Measures Course

The National Pharmaceutical Council (NPC), in partnership with the University of Maryland School of Pharmacy, will launch an educational course that...
Blog Post

CER Tweets of the Week: CER-PCOR Summer Institute, Survey on CER Training Needs (July 27-31)

This week, comparative effectiveness research (CER) stakeholders encouraged Twitter followers to register for the University of Maryland School of...
Newsletter Volume

E.V.I.dently July 2015

NPC MessageWho Can Say What, and When? Could We See Changes in Biopharmaceutical Communications?It’s possible that 2015 could be the year that we see...
Blog Post

CER Tweets of the Week: PCORI Blog on Pipeline to Proposal Initiative, AJMC and V-BID Center Twitter Chat (July 20-24)

This week, comparative effectiveness research (CER) stakeholders shared a blog by the Patient-Centered Outcomes Research Institute (@PCORI) about its...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Press Release

State Medicaid Directors Share Views on Comparative Effectiveness Research And Its Impact on Policy in National Pharmaceutical Council Survey

(Washington, DC, April 16, 2015)—A new survey conducted on behalf of the National Pharmaceutical Council (NPC) shows that state Medicaid directors...
Press Release

NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making

(Washington, DC, March 26, 2015)—A new survey of health care stakeholders reveals continued optimism that comparative effectiveness research (CER)...
Press Release

National Pharmaceutical Council, Discern Health Examine Accountable Care Measures for Specialty Care and Innovative Treatment

Washington, DC (October 28, 2014)— Measuring the quality and cost of health care is an integral part of accountable care, but new research from the...
Commentary and Testimony Page

Chain Drug Review – Commentary: “Health Care Outlook for 2015”

This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
YouTube Videos

NPCNow Podcast: Dr. Mark McClellan on Quality Measures & Engaging Patients

In this NPCNow podcast, Dr. Mark McClellan, director, Health Care Innovation and Value Initiative, Brookings Institution, discusses ways to address...
YouTube Videos

Quality Measures Benefit Patients in More Ways Than One

Cary Sennett, MD, PhD, president and CEO, Asthma and Allergy Foundation of America, explains that quality measures are important to patients not only...
YouTube Videos

Quality Measures: In Theory & In Practice

Cary Sennett, MD, PhD, president and CEO, Asthma and Allergy Foundation of America, explains, in theory, quality measures are important because they...
YouTube Videos

Challenges in Quality Measurement & Potential Solutions

Cary Sennett, MD, PhD, president and CEO, Asthma and Allergy Foundation of America, lists the current challenges involved in quality measurement (e.g...
Blog Post

Why You Need to Register for Our Health Care Quality Measures Course

The National Pharmaceutical Council (NPC), in partnership with the University of Maryland School of Pharmacy, will launch an educational course that...
Blog Post

CER Tweets of the Week: CER-PCOR Summer Institute, Survey on CER Training Needs (July 27-31)

This week, comparative effectiveness research (CER) stakeholders encouraged Twitter followers to register for the University of Maryland School of...
Blog Post

CER Tweets of the Week: PCORI Blog on Pipeline to Proposal Initiative, AJMC and V-BID Center Twitter Chat (July 20-24)

This week, comparative effectiveness research (CER) stakeholders shared a blog by the Patient-Centered Outcomes Research Institute (@PCORI) about its...
Blog Post

Are You a Clinical Decision-Maker? Register for Expert-Endorsed CER Collaborative Tools to Be “Better at What You Do”

The growing availability of new research poses challenges and opportunities for those creating, communicating or using research to inform clinical...
cersurvey-15

2015 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

NPC's fifth annual survey, "Comparative Effectiveness Research (CER) and the Environment for Health...

Accountable Care Measures for High-Cost Specialty Care and Innovative Treatment

This research sheds light on gaps in quality measurement and missed opportunities to promote...
  •  
  • 1 of 25
  • >